Vimarsana
Biggest News Aggregation in the World

Digman Wiklund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Digman Wiklund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Digman Wiklund Today - Breaking & Trending Today

Circio : Terms of the rights issue and related transactions - Vimarsana News

Circio : Terms of the rights issue and related transactions

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, THE UNITED KINGDOM, CANADA, AUSTRALIA, HONG KONG, JAPAN OR ANY...

Circio : Notice of annual general meeting 2024 - Vimarsana News

Circio : Notice of annual general meeting 2024

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY...

Circio : Key information relating to the rights issue - Vimarsana News

Circio : Key information relating to the rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, THE UNITED KINGDOM, CANADA, AUSTRALIA, HONG KONG, JAPAN OR ANY...

Circio Holding ASA: Requested Conversion of Convertible Bonds -December 13, 2023 at 06:31 am EST - Vimarsana News

Circio Holding ASA: Requested Conversion of Convertible Bonds -December 13, 2023 at 06:31 am EST

Reference is made to Circio Holding ASA's stock exchange announcement on 9 March 2023, in which the Company announced that it had requested Atlas Special Opportunities, LLC to subscribe and...

Circio : announces outcome of TG01/gemcitabine combination EU patent proceeding -November 24, 2023 at 07:06 am EST - Vimarsana News

Circio : announces outcome of TG01/gemcitabine combination EU patent proceeding -November 24, 2023 at 07:06 am EST

The EPO board of appeal moved to revoke the TG01/gemcitabine combination method of use patent in pancreatic cancer The TG01 / gemcitabine combination was...